Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
The M2 protein of influenza A virus performs the crucial function of transporting protons to the interior of virions enclosed in the endosome. Adamantane drugs, amantadine (AMN) and rimantidine (RMN), block the proton conduction in some strains, and have been used for the treatment and prophylaxis of influenza A infections. The structures of the transmembrane (TM) region of M2 that have been solved in micelles using NMR (residues 23-60) (Schnell and Chou, 2008) and by X-ray crystallography (residues 22-46) (Stouffer et al., 2008) suggest different drug binding sites: external and internal for RMN and AMN, respectively. We have used molecular dynamics (MD) simulations to investigate the nature of the binding site and binding mode of adamantane drugs on the membrane-bound tetrameric M2-TM peptide bundles using as initial conformations the low-pH AMN-bound crystal structure, a high-pH model derived from the drug-free crystal structure, and the high-pH NMR structure. The MD simulations indicate that under both low- and high-pH conditions, AMN is stable inside the tetrameric bundle, spanning the region between residues Val27 to Gly34. At low pH the polar group of AMN is oriented toward the His37 gate, while under high-pH conditions its orientation exhibits large fluctuations. The present MD simulations also suggest that AMN and RMN molecules do not show strong affinity to the external binding sites.
Khurana
Ekta
E
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA. ekta.khurana@yale.edu
Devane
Russell H
RH
Dal Peraro
Matteo
M
Klein
Michael L
ML
D000547:Amantadine / Q000378:metabolism; D000998:Antiviral Agents / Q000378:metabolism; D001665:Binding Sites; D024882:Drug Resistance, Viral; D006863:Hydrogen-Ion Concentration; D009980:Influenza A virus / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D007473:Ion Channels / Q000737:chemistry* / Q000378:metabolism*; D008823:Micelles; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D019906:Nuclear Magnetic Resonance, Biomolecular; D020836:Protein Structure, Quaternary; D011522:Protons; D012299:Rimantadine / Q000378:metabolism; D014763:Viral Matrix Proteins / Q000737:chemistry* / Q000378:metabolism*; D000086082:Viroporin Proteins
D000547:Amantadine; D000998:Antiviral Agents; D007473:Ion Channels; D008823:Micelles; D011522:Protons; D012299:Rimantadine; D014763:Viral Matrix Proteins; C488937:M2 protein, Influenza A virus; D000086082:Viroporin Proteins
J Comput Chem. 2005 Dec;26(16):1781-802
16222654
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1069-74
19144924
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1483-8
18230730
Biophys J. 2007 Nov 15;93(10):3470-9
17693473
Biophys J. 1997 Nov;73(5):2269-79
9370424
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10967-72
18669647
Nature. 2008 Jan 31;451(7178):591-5
18235503
Biochemistry. 2000 Nov 21;39(46):14160-70
11087364
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
JAMA. 2006 Feb 22;295(8):891-4
16456087
Structure. 2008 Jul;16(7):1067-76
18611380
J Biol Chem. 2002 Oct 18;277(42):39880-6
12183461
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7379-84
19383794
Antiviral Res. 2007 Mar;73(3):228-31
17112602
MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):433-5
19407738
J Phys Chem B. 2008 Jul 10;112(27):7977-9
18476738
J Biol Chem. 2000 Oct 6;275(40):31038-50
10913133
J Am Chem Soc. 2007 May 2;129(17):5719-29
17417850
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11301-6
9326604
Biophys J. 2007 Jul 1;93(1):276-83
17434944
Biophys J. 2007 Jun 15;92(12):4335-43
17384070
Virus Res. 2004 Jan;99(1):57-61
14687947
Protein Sci. 2001 Nov;10(11):2241-50
11604531
J Phys Chem B. 1998 Apr 30;102(18):3586-616
24889800
J Physiol. 2003 Jan 15;546(Pt 2):427-38
12527729
Nature. 2008 Jan 31;451(7178):532-3
18235492
Biochemistry. 2010 Feb 2;49(4):696-708
20028125
Antiviral Res. 2009 Jul;83(1):90-3
19501261
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13311-6
19633188
J Biol Chem. 2000 Mar 24;275(12):8592-9
10722698
Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13
19067613
J Biol Chem. 1999 Feb 26;274(9):5474-82
10026160
Proteins. 2004 May 1;55(2):251-7
15048819
Photochem Photobiol Sci. 2006 Jun;5(6):629-32
16761092
J Mol Biol. 2007 Feb 23;366(3):806-14
17196615
Nature. 2008 Jan 31;451(7178):596-9
18235504
Nature. 2010 Feb 4;463(7281):689-92
20130653
J Virol. 1993 Sep;67(9):5585-94
7688826
Proc Natl Acad Sci U S A. 2006 May 2;103(18):6865-70
16632600
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12283-8
19590009
J Am Chem Soc. 2008 Jan 23;130(3):918-24
18163621
J Med Chem. 1996 Aug 16;39(17):3307-18
8765514